We found 8 episodes of Oncology Today with Dr Neil Love with the tag “covid-19”.
-
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson
August 1st, 2020 | 15 mins 34 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.
-
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2
June 5th, 2020 | 27 mins 40 secs
cancer, cancer treatment, chemotherapy, chronic lymphocytic leukemia, cll, covid, covid-19, dr neil love, hematology, oncology, oncology education, research to practice, sars-cov2
Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2.
-
Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19
May 27th, 2020 | 16 mins 4 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, nurses, nursing, oncology, oncology education, oncology nurse, research to practice, telemedicine
Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care.
-
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era
May 19th, 2020 | 19 mins 32 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.
-
Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic
May 15th, 2020 | 14 mins 26 secs
brca, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, gynecologic cancer, immunotherapy, metastatic, oncology, oncology education, ovarian cancer, parp, research to practice, telemedicine
Dr Kathleen Moore from the Stephenson Cancer Center and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer.
-
Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic
May 3rd, 2020 | 25 mins 13 secs
brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine
Dr Julie Gralow reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19.
-
AACR Virtual Spectacular: Dr Leora Horn Comments on the New COVID-19 Lung Cancer Registry
April 29th, 2020 | 13 mins 20 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
Dr Leora Horn of Vanderbilt University Medical Center discusses outcomes for patients with lung cancer and COVID-19 as well as the human implications of social distancing.
-
Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber
April 24th, 2020 | 28 mins 50 secs
brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine
Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations.